Pan Z[au] - Search Results

Year	Number of Results
1963	1
1979	2
1980	3
1981	3
1982	4
1983	8
1984	5
1985	4
1986	5
1987	9
1988	5
1989	8
1990	5
1991	9
1992	7
1993	11
1994	12
1995	20
1996	22
1997	19
1998	31
1999	33
2000	38
2001	35
2002	44
2003	50
2004	73
2005	79
2006	108
2007	119
2008	134
2009	172
2010	169
2011	206
2012	234
2013	234
2014	279
2015	302
2016	345
2017	394
2018	510
2019	580
2020	644
2021	737
2022	907
2023	484

1

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.

Cheng Y, Han L, Wu L, Chen J, Sun H, Wen G, Ji Y, Dvorkin M, Shi J, Pan Z, Shi J, Wang X, Bai Y, Melkadze T, Pan Y, Min X, Viguro M, Li X, Zhao Y, Yang J, Makharadze T, Arkania E, Kang W, Wang Q, Zhu J; ASTRUM-005 Study Group. Cheng Y, et al. Among authors: pan z. JAMA. 2022 Sep 27;328(12):1223-1232. doi: 10.1001/jama.2022.16464. JAMA. 2022. PMID: 36166026 Free PMC article. Clinical Trial.

2

CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment.

Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, Chen J, Qian Y, Lu X, Li L, Zheng G, Zhang Y, Zou X, Song F, Zheng C, Jiang L, Wang J, Tan Z, Huang P, Ge M. Pan Z, et al. Mol Cancer. 2022 Oct 3;21(1):190. doi: 10.1186/s12943-022-01658-x. Mol Cancer. 2022. PMID: 36192735 Free PMC article.

3

Non-viral precision T cell receptor replacement for personalized cell therapy.

Foy SP, Jacoby K, Bota DA, Hunter T, Pan Z, Stawiski E, Ma Y, Lu W, Peng S, Wang CL, Yuen B, Dalmas O, Heeringa K, Sennino B, Conroy A, Bethune MT, Mende I, White W, Kukreja M, Gunturu S, Humphrey E, Hussaini A, An D, Litterman AJ, Quach BB, Ng AHC, Lu Y, Smith C, Campbell KM, Anaya D, Skrdlant L, Huang EY, Mendoza V, Mathur J, Dengler L, Purandare B, Moot R, Yi MC, Funke R, Sibley A, Stallings-Schmitt T, Oh DY, Chmielowski B, Abedi M, Yuan Y, Sosman JA, Lee SM, Schoenfeld AJ, Baltimore D, Heath JR, Franzusoff A, Ribas A, Rao AV, Mandl SJ. Foy SP, et al. Among authors: pan z. Nature. 2023 Mar;615(7953):687-696. doi: 10.1038/s41586-022-05531-1. Epub 2022 Nov 10. Nature. 2023. PMID: 36356599 Free PMC article. Clinical Trial.

4

Neoantigen-targeted CD8⁺ T cell responses with PD-1 blockade therapy.

Puig-Saus C, Sennino B, Peng S, Wang CL, Pan Z, Yuen B, Purandare B, An D, Quach BB, Nguyen D, Xia H, Jilani S, Shao K, McHugh C, Greer J, Peabody P, Nayak S, Hoover J, Said S, Jacoby K, Dalmas O, Foy SP, Conroy A, Yi MC, Shieh C, Lu W, Heeringa K, Ma Y, Chizari S, Pilling MJ, Ting M, Tunuguntla R, Sandoval S, Moot R, Hunter T, Zhao S, Saco JD, Perez-Garcilazo I, Medina E, Vega-Crespo A, Baselga-Carretero I, Abril-Rodriguez G, Cherry G, Wong DJ, Hundal J, Chmielowski B, Speiser DE, Bethune MT, Bao XR, Gros A, Griffith OL, Griffith M, Heath JR, Franzusoff A, Mandl SJ, Ribas A. Puig-Saus C, et al. Among authors: pan z. Nature. 2023 Mar;615(7953):697-704. doi: 10.1038/s41586-023-05787-1. Epub 2023 Mar 8. Nature. 2023. PMID: 36890230

5

Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer.

Sui Q, Zhang X, Chen C, Tang J, Yu J, Li W, Han K, Jiang W, Liao L, Kong L, Li Y, Hou Z, Zhou C, Zhang C, Zhang L, Xiao B, Mei W, Xu Y, Qin J, Zheng J, Pan Z, Ding PR. Sui Q, et al. Among authors: pan z. Nat Commun. 2022 Nov 28;13(1):7316. doi: 10.1038/s41467-022-35096-6. Nat Commun. 2022. PMID: 36443332 Free PMC article.

6

Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.

Li M, Xu H, Qi Y, Pan Z, Li B, Gao Z, Zhao R, Xue H, Li G. Li M, et al. Among authors: pan z. Oncogene. 2022 Oct;41(41):4618-4632. doi: 10.1038/s41388-022-02457-w. Epub 2022 Sep 9. Oncogene. 2022. PMID: 36085418 Free PMC article.

7

Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer.

Pan Z, Lin H, Fu Y, Zeng F, Gu F, Niu G, Fang J, Gu B. Pan Z, et al. Front Immunol. 2023 Jan 19;14:1086898. doi: 10.3389/fimmu.2023.1086898. eCollection 2023. Front Immunol. 2023. PMID: 36742294 Free PMC article.

8

The N⁶-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.

Li B, Zhao R, Qiu W, Pan Z, Zhao S, Qi Y, Qiu J, Zhang S, Guo Q, Fan Y, Xu H, Li M, Li G, Xue H. Li B, et al. Among authors: pan z. Theranostics. 2022 Aug 29;12(14):6363-6379. doi: 10.7150/thno.74600. eCollection 2022. Theranostics. 2022. PMID: 36168628 Free PMC article.

9

Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis.

He Q, Yang J, Pan Z, Zhang G, Chen B, Li S, Xiao J, Tan F, Wang Z, Chen P, Wang H. He Q, et al. Among authors: pan z. Biomed Pharmacother. 2023 Jan;157:113915. doi: 10.1016/j.biopha.2022.113915. Epub 2022 Nov 12. Biomed Pharmacother. 2023. PMID: 36379122 Free article.

10

Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment.

Shen H, Jin L, Zheng Q, Ye Z, Cheng L, Wu Y, Wu H, Jon TG, Liu W, Pan Z, Mao Z, Wang Y. Shen H, et al. Among authors: pan z. Bioact Mater. 2022 Dec 9;24:37-53. doi: 10.1016/j.bioactmat.2022.12.001. eCollection 2023 Jun. Bioact Mater. 2022. PMID: 36582350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6,390 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6,390 results

Results by year